London · Delayed Price · Currency is GBP · Price in GBX GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of GBP 82.14 billion. The enterprise value is 96.08 billion.
| Market Cap | 82.14B |
| Enterprise Value | 96.08B |
Important Dates
The next estimated earnings date is Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | Feb 19, 2026 |
Share Statistics
GSK plc has 4.00 billion shares outstanding. The number of shares has decreased by -0.60% in one year.
| Current Share Class | 4.00B |
| Shares Outstanding | 4.00B |
| Shares Change (YoY) | -0.60% |
| Shares Change (QoQ) | -0.39% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 86.35% |
| Float | 3.86B |
Valuation Ratios
The trailing PE ratio is 14.80 and the forward PE ratio is 11.42. GSK plc's PEG ratio is 2.07.
| PE Ratio | 14.80 |
| Forward PE | 11.42 |
| PS Ratio | 2.51 |
| PB Ratio | 5.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.85 |
| P/OCF Ratio | 10.61 |
| PEG Ratio | 2.07 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.32, with an EV/FCF ratio of 15.03.
| EV / Earnings | 16.81 |
| EV / Sales | 2.94 |
| EV / EBITDA | 8.32 |
| EV / EBIT | 10.17 |
| EV / FCF | 15.03 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.11.
| Current Ratio | 0.82 |
| Quick Ratio | 0.50 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | 1.54 |
| Debt / FCF | 2.78 |
| Interest Coverage | 14.36 |
Financial Efficiency
Return on equity (ROE) is 43.31% and return on invested capital (ROIC) is 26.53%.
| Return on Equity (ROE) | 43.31% |
| Return on Assets (ROA) | 9.79% |
| Return on Invested Capital (ROIC) | 26.53% |
| Return on Capital Employed (ROCE) | 23.78% |
| Weighted Average Cost of Capital (WACC) | 5.51% |
| Revenue Per Employee | 488,727 |
| Profits Per Employee | 85,516 |
| Employee Count | 66,841 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.54 |
Taxes
In the past 12 months, GSK plc has paid 1.11 billion in taxes.
| Income Tax | 1.11B |
| Effective Tax Rate | 15.02% |
Stock Price Statistics
The stock price has increased by +37.75% in the last 52 weeks. The beta is 0.32, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +37.75% |
| 50-Day Moving Average | 2,039.81 |
| 200-Day Moving Average | 1,709.41 |
| Relative Strength Index (RSI) | 50.92 |
| Average Volume (20 Days) | 8,945,899 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of GBP 32.67 billion and earned 5.72 billion in profits. Earnings per share was 1.39.
| Revenue | 32.67B |
| Gross Profit | 23.72B |
| Operating Income | 9.45B |
| Pretax Income | 7.40B |
| Net Income | 5.72B |
| EBITDA | 11.34B |
| EBIT | 9.45B |
| Earnings Per Share (EPS) | 1.39 |
Balance Sheet
The company has 3.42 billion in cash and 17.79 billion in debt, with a net cash position of -14.37 billion or -3.59 per share.
| Cash & Cash Equivalents | 3.42B |
| Total Debt | 17.79B |
| Net Cash | -14.37B |
| Net Cash Per Share | -3.59 |
| Equity (Book Value) | 15.96B |
| Book Value Per Share | 4.08 |
| Working Capital | -3.88B |
Cash Flow
In the last 12 months, operating cash flow was 7.74 billion and capital expenditures -1.35 billion, giving a free cash flow of 6.39 billion.
| Operating Cash Flow | 7.74B |
| Capital Expenditures | -1.35B |
| Depreciation & Amortization | 1.89B |
| Net Borrowing | 1.27B |
| Free Cash Flow | 6.39B |
| FCF Per Share | 1.60 |
Margins
Gross margin is 72.61%, with operating and profit margins of 28.92% and 17.50%.
| Gross Margin | 72.61% |
| Operating Margin | 28.92% |
| Pretax Margin | 22.66% |
| Profit Margin | 17.50% |
| EBITDA Margin | 34.70% |
| EBIT Margin | 28.92% |
| FCF Margin | 19.57% |
Dividends & Yields
This stock pays an annual dividend of 0.72, which amounts to a dividend yield of 3.51%.
| Dividend Per Share | 0.72 |
| Dividend Yield | 3.51% |
| Dividend Growth (YoY) | 8.20% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 44.86% |
| Buyback Yield | 0.60% |
| Shareholder Yield | 4.25% |
| Earnings Yield | 6.96% |
| FCF Yield | 7.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
| Last Split Date | Jul 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 2.04 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.04 |
| Piotroski F-Score | 7 |